Correlation Between Telix Pharmaceuticals and Maggie Beer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Maggie Beer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Maggie Beer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telix Pharmaceuticals and Maggie Beer Holdings, you can compare the effects of market volatilities on Telix Pharmaceuticals and Maggie Beer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Maggie Beer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Maggie Beer.

Diversification Opportunities for Telix Pharmaceuticals and Maggie Beer

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Telix and Maggie is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Maggie Beer Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maggie Beer Holdings and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Maggie Beer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maggie Beer Holdings has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Maggie Beer go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Maggie Beer

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 0.54 times more return on investment than Maggie Beer. However, Telix Pharmaceuticals is 1.86 times less risky than Maggie Beer. It trades about 0.2 of its potential returns per unit of risk. Maggie Beer Holdings is currently generating about 0.02 per unit of risk. If you would invest  2,336  in Telix Pharmaceuticals on September 28, 2024 and sell it today you would earn a total of  166.00  from holding Telix Pharmaceuticals or generate 7.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Telix Pharmaceuticals  vs.  Maggie Beer Holdings

 Performance 
       Timeline  
Telix Pharmaceuticals 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Maggie Beer Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maggie Beer Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Telix Pharmaceuticals and Maggie Beer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telix Pharmaceuticals and Maggie Beer

The main advantage of trading using opposite Telix Pharmaceuticals and Maggie Beer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Maggie Beer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maggie Beer will offset losses from the drop in Maggie Beer's long position.
The idea behind Telix Pharmaceuticals and Maggie Beer Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities